This presentation describes the work done by Pfizer, as part of MMV, to develop the azithromycin/chloroquine combination to treat malaria in pregnancy in sub-Saharan Africa. Trials in non-pregnant adults have given promising results.
Presentation from MMV 11th stakeholders’ meeting, Dar es Salaam, Tanzania, 2-3 June 2011. Medicines For Malaria Venture, Geneva, Switzerland; 7 pp.
AZCQ IPTp Development Program: An Overview